Oxurion NV (GB:0G99) has released an update.
Oxurion NV, a Belgian biopharmaceutical company, received multiple transparency notifications from Atlas Special Opportunities LLC, indicating significant changes in shareholding. Atlas crossed the 15% threshold on September 24, 2024, fell below it two days later, and then dropped below the 10% threshold by October 2, 2024. These fluctuations in share ownership are reported in compliance with Belgian transparency legislation.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.